Product category:
Contract research
News Release from: ClinPhone | Subject: NCERx
Edited by the Laboratorytalk Editorial
Team on 16 December 2003
Partnership to accelerate patient
recruitment
Companies join forces to transform the methods used by biopharmaceutical companies to contact, recruit and retain clinical trial patients
ClinPhone and NCERx have joined forces to transform the methods used by biopharmaceutical companies to contact, recruit and retain clinical trial patients By integrating ClinPhone's advanced screening, reporting and monitoring systems with the large-scale NCERx healthcare network and informatics platform, the companies have developed a seamless method to accelerate the enrolment of patients into clinical trials via timely information delivery, recruitment and reporting systems
This article was originally published on Laboratorytalk on 20 May 2003 at 8.00am (UK)
Related stories
The 'perfect' patient diary solution
Interactive voice response firm thinks clinical trials industry is not yet fully aware that interactive voice response is the most effective method of gathering patient diary information
IVR becomes 'favoured' patient diary technology
Interactive voice response increasingly seen as preferable to hand held devices for patient data collection services, says promoter of the system
The new programme addresses major bottlenecks in the patient recruitment process, particularly those related to candidate access, communication and follow up.
Advanced data mining techniques will allow sponsors early access to potential patient populations while the advanced messaging opportunities provided by the collaboration will accelerate recruitment and improve retention and compliance.
In the past, many of the major 'traditional' patient recruiting and advertising firms have turned to NCERx to augment their own campaigns.
Further reading
Growth for clinical trials management software
Comprehensive 21 CFR 11 compliant database designed for day-to-day tracking and reporting of regulatory and clinical information
FDA OKs voice response in drug trials
Interactive voice response depression severity assessments are now acceptable to the US Food and Drug Administration in registration trials
Showcasing clinical trials technology
Globally scalable web-based clinical trial management system will be deployed for the day-to-day tracking and reporting of regulatory and clinical information
Now however, sponsors will be able to access these services directly from ClinPhone.
This integration greatly extends the power and reach of ClinPhone's patient recruitment technology.
This latest offering is described as a perfect fit with the company's electronic trial management systems designed to accelerate drug development processes and speed new drugs to market.
ClinPhone can now access, screen, recruit, and randomise patients into studies rapidly, reliably and efficiently.
As a leading healthcare information publisher, NCERx owns a high-traffic network of more than 875 internet sites.
Of these, over 350 are dedicated to providing patients with information on a wide range of conditions and therapeutic classes.
With an annual reach of over 100 million consumers, professionals and patients, the inclusion of lifestyle and health data in the HIPAA-compliant clinical trial database offers biopharmaceutical companies unparalleled and previously unavailable access to a vital patient resource.
Neil Rotherham, ClinPhone's managing director, states: "Industry figures show that a typical clinical trial costs a sponsor between $40,000 and $80,000 a day.
"Therefore, anything that can help to compress study timelines will result in immediate and significant savings.
"Patient recruitment is a key factor in completing studies on time and on budget and is why we have formed this alliance with NCERx.
"Not only does NCERx have the largest pool of opted-in study candidates, but it also has created a real sense of community for these candidates by delivering meaningful, well-researched information to them on a regular basis.
"The combined strengths of our companies will help sponsors to rapidly recruit and retain these patients.
"This deal builds on ClinPhone's reputation for providing practical solutions to clients that deliver real value".
"This agreement benefits patients who are keen to participate in clinical trials and Biopharmaceutical companies researching new therapies," said Colin Lucas-Mudd, CEO of NCERx.
"With the dramatic increase in new chemical entities entering the clinical phase, there is clearly a need for a new, holistic approach to recruitment, compliance and retention.
"We chose ClinPhone to take on marketing our services for multiple reasons. Request a free brochure from ClinPhone ...
"The synergies and limited overlap of the NCERx and ClinPhone technologies, combined with cultural fit and ClinPhone's excellent reputation and market presence made this a very easy agreement to conclude.".
• ClinPhone: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
